ISIN	US37960M1018
ceo	Mr. Andrew Brown

Global Innovative Platforms Inc. engages in the business of testing breath to detect and assist in the treatment of disease. It is developing Heartworm breath test, which includes breath sampler and collection kit, VOCAM gas chromatographer, and machine learning algorithm to replace adult female heartworm antigen blood test in dogs. The company was formerly known as Canning Str Corp. and changed its name to Global Innovative Platforms Inc. in September 2021. The company was incorporated in 2020 and is based in Orlando, Florida.